Hexcel vs. Rocket Lab USA: Which Aerospace Stock Is a Better Buy in 2026?

Article compares Hexcel (HXL) vs. Rocket Lab (RKLB) for 2026, highlighting Hexcel’s FY2025 revenue near $1.9B (-0.5% YoY) and net income of ~$109.4M (net margin ~5.8%) alongside FCF of ~$307.2M and debt-to-equity ~0.8x. Rocket Lab shows FY2025 revenue of ~$601.8M (+38% YoY) but a net loss of ~$198.2M (net margin ~-32.9%), negative FCF of ~$321.8M, while pursuing an ~$8B acquisition of Iridium Communications. The piece concludes Rocket Lab offers the higher upside, despite unprofitability and volatility, while Hexcel is portrayed as steadier but more tied to Airbus/Boeing production rates.

Analysis

The real split here is not “growth vs value,” it is cash-flow visibility versus execution optionality. Hexcel is the cleaner way to express aerospace content because its economics improve when aircraft build rates normalize and stay there; the operating leverage is in margin recovery and cash conversion, not top-line drama. By contrast, Rocket Lab is a long-duration equity story whose valuation is far more sensitive to financing structure, launch cadence, and whether Neutron becomes a repeatable industrial product rather than a science project.

The market likely underestimates how asymmetric the downside is for RKLB if milestones slip. A delay in Neutron, a launch anomaly, or an acquisition funded with dilution-heavy paper would hit the stock twice: lower confidence in the growth runway and multiple compression because there is no earnings buffer. HXL’s risk is more conventional—OEM production volatility—but that is a slower, more recoverable drag with less permanent capital impairment.

Contrarian view: the consensus may be overpaying for the “space platform” narrative while underappreciating incumbent competition in satellite services and the capital intensity required to scale launch infrastructure. If the Iridium transaction is priced aggressively or levered, RKLB could transition from growth darling to balance-sheet story. HXL may look boring, but in a market that is increasingly punishing unprofitable hardware models, boring FCF plus aerospace end-market leverage is often the superior risk-adjusted trade.

Key Decisions for Investors

• Relative-value: long HXL / short RKLB for 6-12 months. Thesis is that HXL’s multiple is backed by cash flow, while RKLB’s valuation is vulnerable to Neutron or financing slippage. Falsify if RKLB delivers visible Neutron milestones and accretive deal terms without dilution.
• If bullish RKLB, express it with a call spread rather than outright common over the next 6-18 months. The stock’s upside is real, but the path dependency is high; paid upside limits damage if launch execution or M&A integration disappoints.
• Use RKLB as a catalyst watch, not a momentum chase: wait for confirmation on acquisition financing, integration terms, and Neutron schedule before adding. Any equity issuance or leverage surprise is a short-on-rallies trigger.
• Accumulate HXL on aerospace pullbacks as a lower-volatility way to own the supply-chain recovery theme. The trade breaks if Airbus/Boeing production expectations roll over for multiple quarters or if margin recovery stalls.